MUMBAI, India, Oct. 24 -- Intellectual Property India has published a patent application (202311089710 A) filed by Ankita Tripathi; Akanksha Pandey; Sapna Chaudhar; Jaideep; Sanjeev Kumar Gautam; Sartaz; Rahul Bhati; Manvender Singh Bhati; and Harish Kumar, Greater Noida, Uttar Pradesh, on Dec. 29, 2023, for 'two-stage oral insulin delivery system.'
Inventor(s) include Ankita Tripathi; Akanksha Pandey; Sapna Chaudhar; Jaideep; Sanjeev Kumar Gautam; Sartaz; Rahul Bhati; Manvender Singh Bhati; and Harish Kumar.
The application for the patent was published on Oct. 24, under issue no. 43/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a two-stage oral insulin delivery system to potentially transform diabetes management. An enteric capsule coated with pHsensitive HP55 protects insulin from stomach enzymes until it reaches the small intestine. Inside, biodegradable PLGA nanoparticles loaded with insulin ensure sustained release for optimal absorption. The optional addition of chitosan, a mucosal penetration enhancer, further improves intestinal uptake. The two-stage oral insulin delivery system offers the convenience and effectiveness of oral insulin therapy, potentially simplifying life for people with diabetes and paving the way for a new era of diabetes management."
Disclaimer: Curated by HT Syndication.
